EUVIMEDEUVIMED entdecken
Multizentrische Studie

Multiple Hematopoietic Stem Cell Transplantations in Pediatric Acute Myeloid Leukemia: Prognostic Significance of Remission and Severe Sinusoidal Obstruction Syndrome

Hideki Yoshida iD, Shotaro Iwamoto, Akira Shimada, Takako Miyamura, Kiminori Terui iD, Hirozumi Sano iD, Akihiro Tamura, Yoko Mizoguchi iD, Kyoko Moritani, Toshihiko Imamura, Yuko Osugi, Asahito Hama

Pediatric Blood & Cancer · 2025

DOI: 10.1002/pbc.32036 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Pediatric Blood & Cancer, 2025. Verfasst von Hideki Yoshida und 11 weiteren Autor:innen. Beteiligte Einrichtung: Acute Myeloid Leukemia Sub-Committee, Association of Childhood Leukemia Study (JACLS), Japan. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Leukemia, Myeloid, Acute, Hepatic Veno-Occlusive Disease. Die Arbeit nennt 38 Literaturangaben. Gefördert von: Japan Leukemia Research Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Relapsed or refractory cases of pediatric acute myeloid leukemia (AML) have poor outcomes despite advancements in chemotherapy and hematopoietic stem cell transplantation (HSCT). While a second HSCT is often a salvage option, its outcomes vary widely, and prognostic factors remain unclear.

Objectives

This study aimed to evaluate outcomes and identify prognostic factors in pediatric patients with AML who underwent multiple HSCTs.

Methods

We conducted a retrospective, multicenter study of 49 pediatric patients with AML who underwent two or more HSCTs at 18 Japan Association of Childhood Leukemia Study institutions during 2000–2019. Clinical data on patient demographics, disease status, transplant characteristics, and complications were collected. The primary endpoint was 5‐year overall survival (OS) after the second HSCT. Kaplan–Meier and multivariate Cox regression analyses were performed.

Results

Of the 49 patients, three and 46 underwent three and two HSCTs, respectively. Among these 46 patients, 5‐year OS after the second HSCT was 28.3%. Achieving hematological complete remission (CR) before the second HSCT was associated with significantly better outcomes (5‐year OS: 45.0% vs. 0%, p < 0.01). Severe sinusoidal obstruction syndrome (SOS) after the second HSCT was a strong predictor of transplant‐related mortality (5‐year OS: 0% in severe SOS cases, p < 0.01). Patient age, donor type, conditioning regimen, and acute/chronic graft‐versus‐host disease were not significantly associated with survival in multivariate analysis.

Conclusions

Achieving CR before the second HSCT is critical for long‐term survival, while severe SOS significantly worsens prognosis. Optimized pre‐transplant strategies to reduce SOS risk are essential to improve outcomes of pediatric patients with AML who undergo multiple HSCTs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hematopoietic Stem Cell TransplantationLeukemia, Myeloid, AcuteHepatic Veno-Occlusive DiseaseHumansMaleFemaleChildRetrospective StudiesPrognosisChild, PreschoolAdolescentSurvival RateInfantRemission InductionFollow-Up StudiesTransplantation Conditioning

Stichwörter der Autor:innen

complete remissionhematopoietic stem cell transplantationpediatric acute myeloid leukemiaprognostic factorssinusoidal obstruction syndrome

Autor:innen und Institutionen

  • Acute Myeloid Leukemia Sub-Committee, Association of Childhood Leukemia Study (JACLS), Japan.
  • Department of Pediatrics, Kyoto Prefectural University of Medicine, Kyoto, Japan.
  • Total Care Center for AYA with Cancer and Children, Mie University Hospital, Tsu, Japan.
  • Department of Pediatrics, Jichi Children's Medical Center Tochigi, Shimono, Japan.
  • Department of Pediatrics, The University of Osaka Graduate School of Medicine, Suita, Japan.
  • Department of Pediatrics, Hirosaki University Hospital, Hirosaki, Japan.

ORCID-Profile: Hideki Yoshida, Kiminori Terui, Hirozumi Sano, Yoko Mizoguchi

Förderung

  • Japan Leukemia Research Fund

Zitieren

APA

Yoshida, H., Iwamoto, S., Shimada, A., Miyamura, T., Terui, K., Sano, H., Tamura, A., Mizoguchi, Y., Moritani, K., Imamura, T., Osugi, Y., & Hama, A. (2025). Multiple Hematopoietic Stem Cell Transplantations in Pediatric Acute Myeloid Leukemia: Prognostic Significance of Remission and Severe Sinusoidal Obstruction Syndrome. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.32036

Vancouver

Yoshida H, Iwamoto S, Shimada A, Miyamura T, Terui K, Sano H, et al. Multiple Hematopoietic Stem Cell Transplantations in Pediatric Acute Myeloid Leukemia: Prognostic Significance of Remission and Severe Sinusoidal Obstruction Syndrome. Pediatric Blood & Cancer. 2025. doi:10.1002/pbc.32036

BibTeX
@article{Yoshida2025,
  author = {Yoshida, Hideki and Iwamoto, Shotaro and Shimada, Akira and Miyamura, Takako and Terui, Kiminori and Sano, Hirozumi and Tamura, Akihiro and Mizoguchi, Yoko and Moritani, Kyoko and Imamura, Toshihiko and Osugi, Yuko and Hama, Asahito},
  title = {Multiple Hematopoietic Stem Cell Transplantations in Pediatric Acute Myeloid Leukemia: Prognostic Significance of Remission and Severe Sinusoidal Obstruction Syndrome},
  journal = {Pediatric Blood & Cancer},
  year = {2025},
  doi = {10.1002/pbc.32036}
}
Kostenlos starten →